Reactive oxygen species-mediated therapeutic control of bladder cancer.
about
SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activationThe roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanismsA redox state-dictated signalling pathway deciphers the malignant cell specificity of CD40-mediated apoptosis.
P2860
Reactive oxygen species-mediated therapeutic control of bladder cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Reactive oxygen species-mediated therapeutic control of bladder cancer.
@en
Reactive oxygen species-mediated therapeutic control of bladder cancer.
@nl
type
label
Reactive oxygen species-mediated therapeutic control of bladder cancer.
@en
Reactive oxygen species-mediated therapeutic control of bladder cancer.
@nl
prefLabel
Reactive oxygen species-mediated therapeutic control of bladder cancer.
@en
Reactive oxygen species-mediated therapeutic control of bladder cancer.
@nl
P2860
P356
P1476
Reactive oxygen species-mediated therapeutic control of bladder cancer.
@en
P2860
P2888
P304
P356
10.1038/NRUROL.2011.135
P407
P577
2011-10-04T00:00:00Z